Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P447: Vedolizumab induces significantly higher endoscopic remission rates at week 16 in ulcerative colitis as compared to Crohn's diseaseECCO '17 Barcelona
Year: 2017
Authors:

Pauwels R.W.M., De Vries A.C., Van der Woude C.J.

Erasmus MC, Department of Gastroenterology and Hepatology, Rotterdam, Netherlands

P448: Biologic therapy and immunodulators are associated with decreased risk of cardiovascular events in patients with immune-mediated inflammatory diseases: a systematic review and meta-analysisECCO '17 Barcelona
Year: 2017
Authors:

Fumery M.*1, Singh A.2, Khera R.3, Prokop L.4, Curtis J.5, Sandborn W.6, Singh S.6

1Amiens University Hospital, Department of Gastroenterology and Hepatology, Amiens, France 2University of California San Diego, La Jolla, Rheumatology, San Diego, United States 3University of Texas Southwestern Medical Center, Divsion of Cardiology, Dallas, United States 4Mayo Clinic, Rochester, United States 5University of Alabama, Clinical immunology and Rheumatology, Alabama, United States 6University of California San Diego, Department of Gastroenterology, La Jolla, United States

P449: Patient support program for adalimumab-treated patients with Crohn's disease in Brazil: impact on patients' adherence and persistenceECCO '17 Barcelona
Year: 2017
Authors:

Teich V.*1, Arinelli R.1, Gulart A.1, Chaves L.2, Garg V.2, Skup M.2

1Sense Company, São Paulo, Brazil 2AbbVie Inc., North Chicago, United States

P450: Reliability assessment of endoscopic scoring tools using central video review of colonoscopies in paediatric patients with ulcerative colitis: data from the Canadian Children IBD NetworkECCO '17 Barcelona
Year: 2017
Authors:

Carman N.*1, Huynh H.2, Walsh C.M.1, Ricciuto A.1, Mouzaki M.1, Crowley E.1, Church P.C.1, Walters T.D.1

1The Hospital for Sick Children, University of Toronto, Gastroenterology Department, Toronto, Canada 2University of Alberta, Edmonton, Canada

P451: Compound IBD patient profiles are related to specific information needs – an Israeli national surveyECCO '17 Barcelona
Year: 2017
Authors:

Daher S.*1, Benson A.1, Walker J.2, Hammerman O.1, Khoury T.1, Naftali T.3,4, Eliakim R.4,5, Ben-Bassat O.4,6, Bernstein C.2, Israeli E.1

1Hadassah-Hebrew university medical center, Institute of gastroenterology and liver diseases, Jerusalem, Israel 2University of Manitoba, IBD Clinical and Research Centre, Winnipeg, Canada 3Meir medical center, Department of Gastroenterology and Hepatology, Kfar Saba, Israel 4Tel-Aviv university, Sackler school of medicine, Tel aviv, Israel 5Sheba medical center, Department of Gastroenterology, Ramat Gan, Israel 6Rabin medical center, IBD center, Petach Tekva, Israel

P452: Silent anaemia predicts treatment change in patients with Crohn's disease in clinical remissionECCO '17 Barcelona
Year: 2017
Authors:

Soufleris K., Kafalis N., Katsoula A., Chatzinakos G., Grammatikos N., Giouleme O.

Ippokration General Hospital of Thessaloniki, Second Propedeutic Department of Internal Medicine, Thessaloniki, Greece

P453: Efficacy of therapeutic drug monitoring of anti-TNF therapy in the control of patients with inflammatory bowel diseaseECCO '17 Barcelona
Year: 2017
Authors:

Bernardo S., Fernandes S., Gonçalves A.R., Baldaia C., Valente A., Moura Santos P., Correia L., Velosa J.

Hospital Santa Maria, CHLN, Department of Gastroenterology and Hepatology, Lisbon, Portugal

P454: Can calcineurin inhibitors induce a durable remission that is maintained with vedolizumab in IBD?ECCO '17 Barcelona
Year: 2017
Authors:

Kassim O.1, Micic D.2, Christensen B.1, Pekow J.1, Sakuraba A.1, Dalal S.1, Rubin D.1, Cohen R.*1

1University of Chicago Medical Center, Department of Gastroenterology, Chicago, United States 2University of Chicago, Department of Gastroenterology, Chicago, United States

P455: Clinical features of tuberculosis infection in inflammatory bowel disease patients on anti-TNF therapyECCO '17 Barcelona
Year: 2017
Authors:

Estévez-Gil M.1, De Castro M.L.*2, Hernández V.2, Pineda J.R.2, Martínez-Cadilla J.2, Pereira S.2, Rodríguez-Prada J.-I.2

1Hospital Alvaro Cunqueiro, Complexo Hospitalario Universitario de Vigo, Instituto de Investigaciόn Biomédica, Medicine, Vigo, Spain 2Hospital Alvaro Cunqueiro, Complexo Hospitalario Universitario de Vigo, Instituto de Investigaciόn Biomédica, Gastroenterology, Vigo, Spain

P456: Comparative analysis of oral versus intravenous iron in patients with inflammatory bowel disease and iron deficiency/anaemia – impact on hospitalisation in GermanyECCO '17 Barcelona
Year: 2017
Authors:

Borchert K.1, Hardt T.2, Haas J.S.1, Ong S.H.3, Lechat E.1, Nip K.2, Foerster D.3, Braun S.1, Stein J.*4,5

1Xcenda GmbH, Hannover, Germany 2Vifor Pharma Deutschland GmbH, Munich, Germany 3Vifor Pharma Ltd., Glattbrugg, Switzerland 4Interdisciplinary Crohn Colitis Centre Rhein-Main, Frankfurt/Main, Germany 5DGD Clinics Sachsenhausen, Frankfurt/Main, Germany

P457: Rapid faecal calprotectin test and symptom index for monitoring the disease activity in colonic IBDECCO '17 Barcelona
Year: 2017
Authors:

Puolanne A.-M.*1, Kolho K.-L.2, Färkkilä M.1

1Helsinki University Hospital, Department of Gastroenterology, Helsinki, Finland 2Helsinki University Hospital for Children and Adolescents, Helsinki, Finland

P458: Sleep problems in inflammatory bowel disease; When bed becomes a battlegroundECCO '17 Barcelona
Year: 2017
Authors:

Green A.*1, Beale A.2, Fraser A.3, Potokar J.3, Durrant C.1, Barnes M.1

1University of Bristol, Department of Social Medicine, Bristol, United Kingdom 2Bristol Royal Infirmary, Gastroenterology, Bristol, United Kingdom 3Bristol Royal Infirmary, Bristol, United Kingdom

P459: Obesity in patients with an ileoanal pouch due to ulcerative colitis is not associated with an increased risk for pouchitisECCO '17 Barcelona
Year: 2017
Authors:

Pfeffer-Gik T.*1, Fishman S.1, Godny L.1, Tulchinsky H.2, Dotan I.1

1Tel Aviv Sourasky Medical Center, IBD Center Department of Gastroenterology and Liver Diseases, Tel Aviv, Israel 2Tel Aviv Sourasky Medical Center, Proctology Unit, Department of Surgery, Tel Aviv, Israel

P460: Early use of therapeutic drug monitoring to individualize infliximab therapy in paediatric IBD: a multicentre prospective COHORT studyECCO '17 Barcelona
Year: 2017
Authors:

Crowley E.*1, Carman N.1, Arpino V.1, Frost K.1, Ricciuto A.1, Sherlock M.2, Critch J.3, Mack D.4, Benchimol E.5, Jacobson K.6, Lawrence S.6, deBruyn J.7, El-Matary W.8, Otley A.9, Huynh H.10, Church P.1, Walters T.1, Griffiths A.1

1Hospital for Sick Children, Division of Gastroenterology, Hepatology and Nutrition, Department of Paediatrics, Toronto, Canada 2McMaster Children's Hospital, Hamilton Health Sciences, Division of Gastroenterology & Nutrition, Hamilton, Canada 3Memorial University of Newfoundland, Division of Gastroenterology, Janeway Children's Health and Rehabilitation Centre, St. John's, Canada 4Children's Hospital of Eastern Ontario IBD Centre, University of Ottawa, Department of Pediatrics, Ottawa, Canada 5University of Ottawa, Children's Hospital of Eastern Ontario IBD Centre, Department of Pediatrics, Ottawa, Canada 6B.C. Children's Hospital, Division of Gastroenterology, Vancouver, Canada 7Faculty of Medicine, University of Calgary, Alberta Children's Hospital, Division of Pediatric Gastroenterology, Department of Pediatrics, Alberta, Canada 8Max Rady College of Medicine, University of Manitoba, Section of Gastroenterology, Department of Pediatrics, Manitoba, Canada 9IWK Health Centre, Department of Pediatrics, Dalhousie University, 5980 University Avenue, Division of Gastroenterology & Nutrition, Halifax, Canada 10Department of Pediatrics, University of Alberta, Edmonton, Edmonton, Canada

P461: Comparison of efficacy of different oral 5-aminosalicylic acid doses for maintenance of remission in ulcerative colitis: a systematic review and meta-analysisECCO '17 Barcelona
Year: 2017
Authors:

Choi C.H.*1, Kim Y.S.2, Moon W.3, Lee B.I.4, Kim E.S.5, Jung Y.6, Park D.I.7, Yoon Y.S.8, Lee H.9, Han D.S.10

1Chung-Ang University College of Medicine, Internal Medicine, Seoul, South Korea 2Seoul Paik Hospital, Inje University College of Medicine, Internal Medicine, Seoul, South Korea 3Kosin University College of Medicine, Internal Medicine, Busan, South Korea 4The Catholic University of Korea College of Medicine, Internal Medicine, Seoul, South Korea 5Kyungpook National University School of Medicine, Internal Medicine, Daegu, South Korea 6Soonchunhyang University College of Medicine, Internal Medicine, Cheonan, South Korea 7Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Internal Medicine, Seoul, South Korea 8Asan Medical Center, University of Ulsan College of Medicine, Surgery, Seoul, South Korea 9Seoul National University Bundang Hospital, Center for Preventive Medicine and Public Health, Seongnam, South Korea 10Hanyang University College of Medicine, Internal Medicine, Guri, South Korea

P462: Long-term outcomes of anti-TNF therapy discontinuation in patients with penetrating Crohn's diseaseECCO '17 Barcelona
Year: 2017
Authors:

Gompertz M., Ricart E., Ordás I., Alfaro I., Lόpez A., Gallego M., Barastegui R., Giner A., Vara A., Masamunt M., Panés J.

Hospital Clinic Barcelona, Department of Gastroenterology, Barcelona, Spain

P463: Recurrence of Crohn's disease after the first surgical interventionECCO '17 Barcelona
Year: 2017
Authors:

Pontes García A.1, Gallardo Valverde J.M.*2, Iglesias Flores E.3, García Sanchez V.3, Díaz Lόpez C.2, Martínez Dueñas J.L.2, Medina J.2, Navarro E.2, Torres E.2, Gόmez Barbadillo J.2

1Universidad de Cόrdoba, Cόrdoba, Spain 2Universidad de Cόrdoba, Cirugía General, Cόrdoba, Spain 3Universidad de Cόrdoba, Digestivo del HURS, Cόrdoba, Spain

P464: Recurrence of ulcerative colitis during pregnancy in patients who became pregnant during remissionECCO '17 Barcelona
Year: 2017
Authors:

Ito A.*1, Murasugi S.2, Kashiwagi H.2, Hara T.2, Omori T.1, Yonezawa M.1, Iizuka B.1, Tokushige K.2

1Tokyo Women's Medical University, Department of Gastroenterology, Tokyo, Japan 2Tokyo Women's Medical Univercity, Tokyo, Japan

P465: Efficacy of ustekinumab for induction and maintenance of histological healing in patients with Crohn's diseaseECCO '17 Barcelona
Year: 2017
Authors:

Li K.*1, Chan D.1, Pollack P.1, Jacobstein D.1, Brodmerkel C.1, Gasink C.1, Feagan B.G.2, Sandborn W.3, Rutgeerts P.4, De Hertogh G.5

1Janssen Research & Development, LLC, Spring House, United States 2Robarts Clinical Trials, Robarts Research Institute, Western University, London, Ont, Canada 3University of California San Diego, La Jolla, United States 4University Hospital, Gasthuisberg, Leuven, Belgium 5University Hospital Gasthuisberg, Leuven, Belgium

P466: Real world effectiveness of vedolizumab over one year in inflammatory bowel disease: a meta-analysisECCO '17 Barcelona
Year: 2017
Authors:

Schreiber S.1, Dignass A.*2, Peyrin-Biroulet L.3, Hather G.4, Demuth D.5, Khalid J.M.6, Loftus E.V.7

1University Hospital Schleswig-Holstein, Institute for Clinical Molecular Biology, Kiel, Germany 2Agaplesion Markus Hospital, Department of Medicine 1, Frankfurt/Main, Germany 3Nancy University Hospital, Dpt. Gastroenterology, Vandoeuvre, France 4Takeda Development Center, Stats Innovation, Massachusetts, United Kingdom 5Takeda Development Center Europe Ltd, Evidence and Value Generation, London, United Kingdom 6Takeda Development Centre Europe Ltd, Evidence and Value Generation, London, United Kingdom 7Mayo Clinic College of Medicine, Gastroenterology and Hepatology, Minnesota, United Kingdom